Metastatic melanoma patient discusses how T-cell therapy saved her life Nicho Bourque, a metastatic melanoma patient, was the first MD Anderson clinical trial patient to receive a new form of adoptive T-cell therapy, called T-cell therapy with dendritic cells. Learn about her experience with the treatment. Bourque was under the care of Nicholas Papadopoulos, M.D.